Shandong Sito Bio-technology Co., Ltd.
SZSE:300583.SZ
16.34 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 322.254 | 244.396 | 356.558 | 259.57 | 328.87 | 334.786 | 379.159 | 296.71 | 382.596 | 253.647 | 320.546 | 258.469 | 351.232 | 272.376 | 188.179 | 232.089 | 270.748 | 222.171 | 179.006 | 206.999 | 292.475 | 287.321 | 205.137 | 286.509 | 319.951 | 240.68 | 282.302 | 197.437 | 202.757 | 103.071 | 186.854 | 118.031 | 216.211 | 47.149 | 180.744 |
| Cost of Revenue
| 245.574 | 174.821 | 309.463 | 201.135 | 237.841 | 245.803 | 340.056 | 222.41 | 299.167 | 177.669 | 263.315 | 191.296 | 276.082 | 206.343 | 172.828 | 196.313 | 252.13 | 184.31 | 146.36 | 142.044 | 219.493 | 222.185 | 151.249 | 231.962 | 235.992 | 165.554 | 195.878 | 164.253 | 160.438 | 82.374 | 377.218 | 76.34 | 139.459 | 22.09 | 372.528 |
| Gross Profit
| 76.68 | 69.574 | 47.095 | 58.435 | 91.028 | 88.982 | 39.103 | 74.299 | 83.429 | 75.978 | 57.231 | 67.173 | 75.15 | 66.033 | 15.351 | 35.776 | 18.618 | 37.861 | 32.646 | 64.955 | 72.982 | 65.137 | 53.888 | 54.547 | 83.959 | 75.126 | 86.423 | 33.184 | 42.319 | 20.697 | -190.364 | 41.691 | 76.752 | 25.059 | -191.784 |
| Gross Profit Ratio
| 0.238 | 0.285 | 0.132 | 0.225 | 0.277 | 0.266 | 0.103 | 0.25 | 0.218 | 0.3 | 0.179 | 0.26 | 0.214 | 0.242 | 0.082 | 0.154 | 0.069 | 0.17 | 0.182 | 0.314 | 0.25 | 0.227 | 0.263 | 0.19 | 0.262 | 0.312 | 0.306 | 0.168 | 0.209 | 0.201 | -1.019 | 0.353 | 0.355 | 0.531 | -1.061 |
| Reseach & Development Expenses
| 17.175 | 14.322 | 13.349 | 13.814 | 13.914 | 13.999 | 18.347 | 12.188 | 12.534 | 7.137 | 15.59 | 8.435 | 14.42 | 11.286 | 19.953 | 8.231 | 9.428 | 7.396 | 24.833 | 11.712 | 13.37 | 5.872 | 5.247 | 5.646 | 22.007 | 6.52 | 14.387 | 7.287 | 10.306 | 0 | 19.147 | 0 | 10.271 | 0 | 22.673 |
| General & Administrative Expenses
| -7.711 | 31.757 | -61.66 | 80.04 | -11.898 | 36.344 | -61.052 | 78.033 | -16.278 | 36.563 | -50.956 | 59.578 | -6.862 | 33.562 | -67.154 | 29.303 | -19.357 | 41.311 | -21.113 | 20.601 | -6.145 | 16.744 | -9.201 | 13.428 | -15.975 | 25.062 | -30.485 | 15.644 | -3.648 | 11.526 | 9.646 | 12.748 | -7.969 | 12.845 | 46.363 |
| Selling & Marketing Expenses
| 5.02 | 4.162 | 3.951 | 3.518 | 4.335 | 3.862 | 5.906 | 2.419 | 2.866 | 3.423 | -1.58 | 4.262 | 8.26 | 2.813 | 3.252 | 3.846 | 6.559 | 1.82 | 6.379 | 1.696 | 2.17 | 2.001 | 1.261 | 2.181 | 3.927 | 2.603 | 3.107 | 2.65 | 2.821 | 2.615 | 1.064 | 2.093 | 1.461 | 1.378 | 5.839 |
| SG&A
| -2.691 | 35.92 | -57.709 | 83.558 | -7.562 | 40.206 | -55.146 | 80.452 | -13.413 | 39.986 | -52.536 | 63.84 | 1.399 | 36.375 | -63.902 | 33.149 | -12.797 | 43.131 | -14.734 | 22.297 | -3.975 | 18.744 | -7.94 | 15.609 | -12.048 | 27.664 | -27.378 | 18.294 | -0.827 | 14.141 | 10.71 | 14.841 | -6.508 | 14.222 | 55.522 |
| Other Expenses
| -0.437 | -0.001 | -3.458 | -0.302 | 24.499 | 0.002 | -1.123 | -0.156 | -0.009 | -0.026 | -1.393 | -0.046 | 0.037 | -0.282 | -4.849 | -0.216 | -0.469 | -0.757 | -2.534 | 0.025 | 0.029 | -0.008 | -0.362 | -0.002 | -0.024 | 0.006 | -1.231 | 0.166 | 0.555 | 0.112 | 1.027 | 0.028 | 0.045 | 0.342 | 239.047 |
| Operating Expenses
| 59.542 | 50.104 | 36.367 | 54.421 | 53.101 | 56.882 | 44.551 | 46.98 | 48.853 | 48.75 | 42.323 | 37.126 | 42.315 | 46.765 | 59.031 | 42.343 | 34.806 | 50.94 | 59.645 | 34.515 | 31.141 | 23.883 | 30.796 | 22.508 | 39.297 | 28.95 | 31.018 | 20.485 | 22.628 | 15.212 | 14.701 | 15.411 | 16.287 | 14.562 | 239.047 |
| Operating Income
| 11.293 | 8.082 | -14.772 | 1.68 | 25.884 | 19.947 | -4.207 | 9.952 | 29.414 | 14.066 | 13.43 | 19.111 | 28.105 | -4.673 | -132.112 | -11.99 | -13.781 | -28.274 | -29.523 | 24.211 | 34.755 | 37.751 | 27.723 | 34.888 | 53.25 | 34.068 | 54.254 | 20.826 | 24.167 | 4.556 | 33.075 | 22.005 | 52.097 | 7.249 | 47.263 |
| Operating Income Ratio
| 0.035 | 0.033 | -0.041 | 0.006 | 0.079 | 0.06 | -0.011 | 0.034 | 0.077 | 0.055 | 0.042 | 0.074 | 0.08 | -0.017 | -0.702 | -0.052 | -0.051 | -0.127 | -0.165 | 0.117 | 0.119 | 0.131 | 0.135 | 0.122 | 0.166 | 0.142 | 0.192 | 0.105 | 0.119 | 0.044 | 0.177 | 0.186 | 0.241 | 0.154 | 0.261 |
| Total Other Income Expenses Net
| -0.437 | -0.001 | -3.458 | -0.302 | 24.499 | 0.002 | -1.123 | -0.156 | -0.009 | -0.026 | -1.393 | -0.046 | 0.037 | -0.282 | -4.849 | -0.216 | -0.469 | -0.757 | -2.534 | 0.025 | 0.029 | -0.008 | -0.362 | -0.002 | -0.024 | 0.006 | -1.231 | 0.166 | 0.418 | 0.112 | 1.013 | 0.028 | 0.045 | 0.342 | -0.08 |
| Income Before Tax
| 10.856 | 8.081 | -18.231 | 1.378 | 50.383 | 19.949 | -5.33 | 9.796 | 29.405 | 14.04 | 12.037 | 19.066 | 28.141 | -4.955 | -136.961 | -12.206 | -14.251 | -29.032 | -32.057 | 24.237 | 34.784 | 37.743 | 27.361 | 34.885 | 53.226 | 34.074 | 53.023 | 20.991 | 24.585 | 4.668 | 34.088 | 22.032 | 52.142 | 7.591 | 47.183 |
| Income Before Tax Ratio
| 0.034 | 0.033 | -0.051 | 0.005 | 0.153 | 0.06 | -0.014 | 0.033 | 0.077 | 0.055 | 0.038 | 0.074 | 0.08 | -0.018 | -0.728 | -0.053 | -0.053 | -0.131 | -0.179 | 0.117 | 0.119 | 0.131 | 0.133 | 0.122 | 0.166 | 0.142 | 0.188 | 0.106 | 0.121 | 0.045 | 0.182 | 0.187 | 0.241 | 0.161 | 0.261 |
| Income Tax Expense
| 1.596 | 4.369 | 1.032 | 0.348 | 1.128 | 2.424 | -8.095 | 1.687 | 9.523 | 2.318 | 6.458 | 6.885 | 5.059 | 0.1 | -6.626 | 1.342 | 1.931 | 0.522 | 1.33 | 4.944 | 3.553 | 5.834 | 1.123 | 4.765 | 12.585 | 4.124 | 7.526 | 5.293 | 3.299 | 1.395 | 4.872 | 3.839 | 8.882 | 1.911 | 4.166 |
| Net Income
| 10.141 | 3.071 | -15.553 | 1.19 | 44.612 | 15.355 | 0.674 | 8.967 | 19.599 | 12.74 | 4.623 | 12.578 | 24.375 | -5.371 | -130.681 | -12.075 | -12.807 | -24.243 | -27.92 | 19.792 | 31.392 | 32.045 | 27.079 | 29.814 | 40.378 | 29.577 | 46.875 | 17.202 | 23.596 | 4.329 | 28.809 | 19.706 | 46.059 | 6.603 | 43.017 |
| Net Income Ratio
| 0.031 | 0.013 | -0.044 | 0.005 | 0.136 | 0.046 | 0.002 | 0.03 | 0.051 | 0.05 | 0.014 | 0.049 | 0.069 | -0.02 | -0.694 | -0.052 | -0.047 | -0.109 | -0.156 | 0.096 | 0.107 | 0.112 | 0.132 | 0.104 | 0.126 | 0.123 | 0.166 | 0.087 | 0.116 | 0.042 | 0.154 | 0.167 | 0.213 | 0.14 | 0.238 |
| EPS
| 0.054 | 0.02 | -0.082 | 0.006 | 0.25 | 0.09 | 0.004 | 0.052 | 0.11 | 0.075 | 0.025 | 0.075 | 0.14 | -0.031 | -0.76 | -0.071 | -0.079 | -0.22 | -0.17 | 0.19 | 0.18 | 0.3 | 0.16 | 0.27 | 0.24 | 0.27 | 0.27 | 0.16 | 0.15 | 0.041 | 0.22 | 0.25 | 0.36 | 0.083 | 0.34 |
| EPS Diluted
| 0.054 | 0.02 | -0.082 | 0.006 | 0.25 | 0.09 | 0.004 | 0.052 | 0.11 | 0.075 | 0.025 | 0.075 | 0.14 | -0.031 | -0.76 | -0.07 | -0.079 | -0.22 | -0.17 | 0.19 | 0.18 | 0.3 | 0.16 | 0.27 | 0.24 | 0.27 | 0.27 | 0.16 | 0.15 | 0.041 | 0.22 | 0.25 | 0.36 | 0.083 | 0.34 |
| EBITDA
| 23.598 | 21.276 | 6.341 | 5.975 | 62.817 | 34.386 | 0.073 | 29.272 | 35.206 | 27.585 | 15.56 | 30.749 | 33.306 | 20.395 | -29.091 | -4.605 | -13.89 | -10.87 | -28.508 | 33.952 | 45.955 | 44.533 | 28.072 | 38.092 | 41.406 | 60.814 | 71.402 | 15.85 | 25.91 | 7.836 | -253.144 | 26.943 | 60.781 | 9.411 | -256.527 |
| EBITDA Ratio
| 0.073 | 0.087 | 0.018 | 0.023 | 0.191 | 0.103 | 0 | 0.099 | 0.092 | 0.109 | 0.049 | 0.119 | 0.095 | 0.075 | -0.155 | -0.02 | -0.051 | -0.049 | -0.159 | 0.164 | 0.157 | 0.155 | 0.137 | 0.133 | 0.129 | 0.253 | 0.253 | 0.08 | 0.128 | 0.076 | -1.355 | 0.228 | 0.281 | 0.2 | -1.419 |